acetylglucosamine has been researched along with Carcinoma, Renal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, SY; Fu, B; Hou, DY; Kong, B; Li, C; Li, LL; Liu, C; Lv, YL; Qiu, Y; Shen, JC; Wang, H; Wang, HL; Wang, L; Xu, WH; Yang, G; Zhang, JJ; Zheng, LB | 1 |
1 other study(ies) available for acetylglucosamine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
PKM2 allosteric converter: A self-assembly peptide for suppressing renal cell carcinoma and sensitizing chemotherapy.
Topics: Acetylglucosamine; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Kidney Neoplasms; Peptides; Pyruvate Kinase | 2023 |